A Managed Care Perspective: Treatment of Idiopathic Pulmonary Fibrosis

An analysis revealed global trends and emerging focus areas in Duchenne muscular dystrophy (DMD) research, emphasizing the growing impact of precision medicine and gene therapies.

Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.

The Center on Health Equity & Access provides news and expert insights on research, health policy, and the impact of social determinants on health.

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

The FDA issued a complete response letter for sotagliflozin (Zynquista) as an adjunct to insulin therapy for glycemic control.

The approval was based on the results of the SURMOUNT-OSA trial, which found patients had fewer breathing disruptions.